What Are The Factors That Affect Post COVID 1st Month's Continuing Symptoms?

Abstract

Aim: The aim of our research was to investigate retrospectively the relationship between the symptoms and general characteristics, initial laboratory values and treatments in patients who had COVID- 19 and who applied to the chest diseases outpatient clinic for control after 1 month. Methods: Three hundred fifteen patients who were diagnosed with COVID- 19 and applied to the chest diseases outpatient clinic between May 2020 and August 2020 for control in the 1st month were included in the study. Patient information was collected from the hospital information system and the e-pulse system. Results: Females accounted for 50.2 % of the our patients and their mean age was 47.98 ± 14.81 (19-88) years. 14.3% (n: 45) of the individuals were 65 years of age and older. 20.6% (n: 65) of our patients were smoking. 70.2% (n: 221) of our patients were treated at home. 133 patients had at least one comorbid disease. The patients most frequently reported cough, dyspnea, weakness, myalgia and diarrhea. The most common symptoms were cough, dyspnea, weakness and myalgia in the first month. It was determined that the symptoms had persisted in patients who had been hospitalized, had dual therapy, had comorbid diseases and had more common pathologies in their pulmonary imagings. Conclusion: Symptoms may persist for a long time in hospitalized patients, in patients with COVID-19-related pneumonia and concomitant chronic diseases and in patients with high d-dimer and high CRP at the time of admission. Patients are informed that their symptoms may last for a long time, unnecessary hospital admissons can be avoided.

The Multisystem Impact of Long COVID: A Comprehensive Review

“…Gastrointestinal (GI) manifestations are one of the main organ-specific complications of acute and Long COVID, and this is believed to be due to the ACE2-expressing cells on the brush border of the small intestinal mucosa [100][101][102][103][104][105][106][107][108][109]. The GI symptoms displayed during acute COVID-19 differ from those displayed in post-COVID-19 syndromes.…”

“…The GI symptoms displayed during acute COVID-19 differ from those displayed in post-COVID-19 syndromes. The acute symptoms are predominantly abdominal pain, nausea, vomiting, diarrhea, and abnormal liver function tests [105,108,110,111]. The post-COVID-19 syndrome manifestations present as loss of appetite, irritable bowel syndrome, weight loss, altered bowel motility, and dysphagia [101,108].…”